| Primary |
|
|
| Secondary |
| Drug Use For Unknown Indication |
46.2% |
| Hypertension |
19.2% |
| Atrial Fibrillation |
7.7% |
| Dementia |
7.7% |
| Eye Disorder |
7.7% |
| Hyperprolactinaemia |
3.8% |
| Osteolysis |
3.8% |
| Parkinson's Disease |
3.8% |
|
| Fall |
40.0% |
| X-ray Abnormal |
40.0% |
| Renal Failure Acute |
20.0% |
|
| Concomitant |
| Hypertension |
27.5% |
| Drug Use For Unknown Indication |
15.6% |
| Product Used For Unknown Indication |
8.8% |
| Type 2 Diabetes Mellitus |
6.0% |
| Coronary Artery Disease |
4.2% |
| Cardiac Failure |
3.9% |
| Colorectal Cancer Metastatic |
3.9% |
| Depression |
3.4% |
| Hepatic Neoplasm Malignant |
3.1% |
| Multiple Myeloma |
3.1% |
| Thrombosis Prophylaxis |
2.3% |
| Urinary Tract Infection |
2.3% |
| Breast Cancer |
2.1% |
| Breast Cancer Metastatic |
2.1% |
| Hormone Replacement Therapy |
2.1% |
| Prophylaxis |
2.1% |
| Rheumatoid Arthritis |
2.1% |
| Atrial Fibrillation |
1.8% |
| Metastasis |
1.8% |
| Osteoporosis |
1.8% |
|
| Sedation |
7.3% |
| Upper-airway Cough Syndrome |
7.3% |
| Ventricular Extrasystoles |
7.3% |
| Anaphylactic Shock |
5.5% |
| Angioedema |
5.5% |
| Basal Cell Carcinoma |
5.5% |
| Hypotonia |
5.5% |
| Myocardial Infarction |
5.5% |
| Pneumonia |
5.5% |
| Tachycardia |
5.5% |
| Viral Infection |
5.5% |
| Wrong Technique In Drug Usage Process |
5.5% |
| Arthralgia |
3.6% |
| Breast Cancer Female |
3.6% |
| C-reactive Protein Increased |
3.6% |
| Dermatitis Allergic |
3.6% |
| Fracture Nonunion |
3.6% |
| Hyperkalaemia |
3.6% |
| Incorrect Drug Administration Duration |
3.6% |
| Insomnia |
3.6% |
|
| Interacting |
| Hypertension |
37.5% |
| Atrial Fibrillation |
25.0% |
| Hyperlipidaemia |
12.5% |
| Osteolysis |
12.5% |
| Parkinson's Disease |
12.5% |
|
| Renal Failure Acute |
100.0% |
|
